Inhomogenous distribution of glutaron in organs and tissues was found after intravenous and peroral administration: the agent demonstrated high affi nity to organs with high degree of vascularization (lungs and heart) and elimination (kidney). Glutaron easily penetrates through the blood-brain barrier, which is consistent with its concentration in the adipose tissue.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. P. Zherdev, S. S. Boiko, N. V. Mesonzhnik, et al., Eksp. Klin. Farmakol., 72, No. 3, 16-21 (2009).
M. V. Karlina, O. N. Pozharitskaya, V. M. Kosman, et al., Eksp. Klin. Farmakol., 73, No. 8, 46-48 (2010).
V. I. Petrov, I. N. Tyurenkov, V. V. Bagmetova, et al., Patent RF No. 2429834, Substance with Antidepressive, Anxiolytic, Neuroprotective, and Immunostimulating Effects, Byull., No. 27, September 27, 2011.
Manual for Performance of Preclinical Studies [in Russian], Ed. A. N. Mironov, Tula (2012).
A. A. Spasov, L. A. Smirnova, I. N. Iyozhitsa, et al., Vopr. Med. Khimii, 48, No. 3, 233-258 (2002).
I. N. Tyurenkov, V. V. Bagmetova, Yu. V. Chernysheva, et al., Vestn. Vol. Gos. Med. Univer., No. 3, 21-24 (2012).
I. N. Tyurenkov, V. N. Perfilova, L. A. Smirnova, et al., Khim. Farm. Zh., 44, No. 12, 53-56 (2010).
I. N. Tyurenkov, V. N. Perfilova, L. A. Smirnova, et al., Khim. Farm. Zh., 47, No. 3, 55-56 (2013).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 159, No. 2, pp. 188-191, February, 2015
Rights and permissions
About this article
Cite this article
Smirnova, L.A., Ryabukha, A.F., Kuznetsov, K.A. et al. Pharmacokinetic Properties of a New Glutamic Acid Derivative Glutaron. Bull Exp Biol Med 159, 229–231 (2015). https://doi.org/10.1007/s10517-015-2929-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-015-2929-2